MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cnr2.2054

Медицинская библиотека · Cancer reports (Hoboken, N.J.) · 2024

Programmed death-ligand 1 expression in patients with primary or secondary myelofibrosis.

Ibrahim Moayed, Murphree Catherine, Patel Kirtesh, Mastrodomenico Matthew, Saba Nakhle S, Safah Hana, Schmid Janet, Socola Francisco

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

It has been described in mice models that myeloproliferative neoplasm (MPN) with JAK2-V617F mutation has an increased expression of programmed death-ligand 1 (PD-L1) in megakaryocytes leading to cancer immune evasion by inhibiting the T-lymphocytes.

AIMS: To quantify and compare the PD-L1 expression on bone marrow (BM) of patients with MPN JAK2 positive, negative, and normal controls.

METHODS

We collected BM of patients with MPN JAK2 positive, negative and normal controls from 1990 to 2019. We also created a scoring system to quantify PD-L1 expression in megakaryocytes.

RESULTS

We obtained 14 BM with JAK2 positive PMF, 5 JAK2 negative PMF, and 10 patients with normal BM biopsies. PD-L1 expression was higher in the JAK2 positive group compared with the control group with a score of 212.6 versus 121.1 (t-value 2.05, p-value 0.025). In addition, the score was higher in the PMF group regardless of JAK2 mutational status when compared with the control group with score of 205.9 versus 121.1 (t-value 2.12, p-value 0.021). There was no difference in the PD-L1 score between the JAK2 negative versus the control group 187.2 versus 121.1 (t-value 1.02, p-value 0.162).

CONCLUSION

These findings suggest that PMF patients with a JAK2 mutation have a higher PD-L1 expression in megakaryocytes compared with the control group. We postulate that the combination of checkpoint and JAK2 inhibitors may be an active treatment option in JAK2 mutated PMF given the higher PD-L1 expression.

Для цитирования: Ibrahim Moayed, Murphree Catherine, Patel Kirtesh, Mastrodomenico Matthew, Saba Nakhle S, Safah Hana, Schmid Janet, Socola Francisco. Programmed death-ligand 1 expression in patients with primary or secondary myelofibrosis.. Cancer reports (Hoboken, N.J.). 2024. DOI: 10.1002/cnr2.2054.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.